Evidence map›Paper›PMID 37430091›Full record

ArticleNature genetics2023

RNA polymerase II dynamics shape enhancer-promoter interactions.

Gilad Barshad, James J Lewis, Alexandra G Chivu, Abderhman Abuhashem, Nils Krietenstein, Edward J Rice, Yitian Ma, Zhong Wang, Oliver J Rando, Anna-Katerina Hadjantonakis and 1 more

Abstract read
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Transcription and Three-Dimensional Genome Organization: Cause, Consequence, or Coordination?BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Exhausted CD8Nature immunology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Enhancer hubs govern chromatin topology and Th17 cell identity.bioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Gilad BarshadBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0001-7845-7658
James J LewisBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Alexandra G ChivuBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Abderhman AbuhashemDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.ORCID http://orcid.org/0000-0002-6135-5679
Nils KrietensteinThe Novo Nordisk Center for Protein Research (CPR), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Edward J RiceBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Yitian MaSchool of Life and Pharmaceutical Sciences, Dalian University of Technology, Dalian, China.
Zhong WangSchool of Life and Pharmaceutical Sciences, Dalian University of Technology, Dalian, China.
Oliver J RandoDepartment of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-1516-9397
Anna-Katerina HadjantonakisDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
Charles G DankoBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. dankoc@gmail.com.ORCID http://orcid.org/0000-0002-1999-7125

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Mechanisms driving cell fate specification and morphogenesis in the blastocystR01HD094868 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI ANNA-KATERINA HADJANTONAKIS · 2018 to 2026
$4.2M
Phenotyping Early Embryonic Lethal Knockout Mice to Identify Essential Genes with Previously Uncharacterized Roles in Pre-implantation Development, Gastrulation, Turning, and PlacentationR01HD086478 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI HADJANTONAKIS, ANNA-KATERINA · 2016 to 2020
$3.4M
The gut endoderm: origin, formation and fateR01DK127821 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI ANNA-KATERINA HADJANTONAKIS · 2021 to 2026
$3.4M
Evolution of Chromatin Architecture and Transcriptional Regulation in MammalsR01HG010346 · NHGRI · CORNELL UNIVERSITY · PI DANKO, CHARLES GRAHE, SIEPEL, ADAM CHARLES · 2019 to 2022
$2.7M
Mapping RNA polymerase in tissue samples with ChRO-seq.R01HG009309 · NHGRI · CORNELL UNIVERSITY · PI DANKO, CHARLES GRAHE · 2017 to 2021
$1.9M
Dissecting the Role of RNA Pol II Pausing in Early Mammalian DevelopmentF30HD103398 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI ABUHASHEM, ABDERHMAN ANEES · 2021 to 2024
$178k
NCI NIH HHS P30 CA008748NHGRI NIH HHS R01 HG009309NHGRI NIH HHS R01 HG010346NICHD NIH HHS F30 HD103398NICHD NIH HHS R01 HD086478NICHD NIH HHS R01 HD094868NIDDK NIH HHS R01 DK127821NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

How enhancers control target gene expression over long genomic distances remains an important unsolved problem. Here we investigated enhancer-promoter communication by integrating data from nucleosome-resolution genomic contact maps, nascent transcription and perturbations affecting either RNA polymerase II (Pol II) dynamics or the activity of thousands of candidate enhancers. Integration of new Micro-C experiments with published CRISPRi data demonstrated that enhancers spend more time in close proximity to their target promoters in functional enhancer-promoter pairs compared to nonfunctional pairs, which can be attributed in part to factors unrelated to genomic position. Manipulation of the transcription cycle demonstrated a key role for Pol II in enhancer-promoter interactions. Notably, promoter-proximal paused Pol II itself partially stabilized interactions. We propose an updated model in which elements of transcriptional dynamics shape the duration or frequency of interactions to facilitate enhancer-promoter communication.

Indexed as

Enhancer Elements, GeneticRNA Polymerase IIPromoter Regions, GeneticTranscription, GeneticRNA Polymerase II

Identifiers

PMID37430091
PMCPMC10714922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.